​

DBV (DBVT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

DBVT Stock Forecast

DBV (DBVT) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $46.33, with a high of $51.00 and a low of $40.00. This represents a 102.58% increase from the last price of $22.87.

- $11 $22 $33 $44 $55 High: $51 Avg: $46.33 Low: $40 Last Closed Price: $22.87

DBVT Stock Rating

DBV stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (66.67%), 4 Hold (26.67%), 1 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 15 1 4 10 0 Strong Sell Sell Hold Buy Strong Buy

DBVT Price Target Upside V Benchmarks

TypeNameUpside
StockDBV102.58%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-67
Avg Price Target-$41.83$38.14
Last Closing Price$22.87$22.87$22.87
Upside/Downside-82.90%66.77%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2614-1-6
Dec, 2512-1-4
Nov, 2521-1-4
Oct, 2521-1-4
Sep, 2521-1-4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 18, 2025Andrew FeinH.C. Wainwright$40.00$22.5577.38%74.90%
Dec 17, 2025Kristen KluskaCantor Fitzgerald$48.00$22.92109.42%109.88%
Dec 17, 2025Yatin SunejaGuggenheim$51.00$17.98183.65%123.00%
Dec 15, 2025Andrew FeinH.C. Wainwright$35.00$19.1183.15%53.04%
Dec 14, 2025Kristen KluskaCantor Fitzgerald$42.00$18.38128.51%83.65%
Dec 03, 2025Guggenheim$35.00$12.90171.32%53.04%
May 05, 2025Andrew FeinH.C. Wainwright$16.00$9.2572.97%-30.04%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 17, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 17, 2025CitigroupOutperformOutperformhold
Dec 17, 2025CitigroupMarket OutperformMarket Outperformhold
Dec 17, 2025GuggenheimBuyBuyhold
Dec 15, 2025H.C. WainwrightBuyBuyhold
Dec 14, 2025Cantor FitzgeraldOverweightinitialise
Dec 03, 2025GuggenheimBuyinitialise
Oct 29, 2025H.C. WainwrightBuyBuyhold
May 27, 2025CitigroupOutperformOutperformhold
May 05, 2025H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.78$-1.24$-0.76-----
Avg Forecast$-2.85$-7.68$-5.63$-4.88$-4.42$-6.35$-5.14$-2.43
High Forecast$-2.75$-7.40$-5.36$-4.65$-4.21$-6.05$-4.90$-2.31
Low Forecast$-3.03$-7.97$-5.90$-5.12$-4.63$-6.65$-5.39$-2.54
Surprise %-37.54%-83.85%-86.50%-----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.71M$4.80M------
Avg Forecast$4.74M$5.70M$6.03M$3.10M$3.17M$37.55M$143.32M$317.48M
High Forecast$4.96M$5.86M$6.25M$3.21M$3.29M$38.92M$148.55M$329.06M
Low Forecast$4.60M$5.53M$5.81M$2.99M$3.06M$36.18M$138.09M$305.90M
Surprise %20.48%-15.72%------

Net Income Forecast

$-800M $-650M $-500M $-350M $-200M $-50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-97.81M$-96.30M$-72.73M-----
Avg Forecast$-271.47M$-730.72M$-535.68M$-464.65M$-420.57M$-604.31M$-489.12M$-230.72M
High Forecast$-261.54M$-703.44M$-510.28M$-442.61M$-400.63M$-575.66M$-465.93M$-219.78M
Low Forecast$-288.31M$-758.00M$-561.08M$-486.68M$-440.52M$-632.97M$-512.31M$-241.66M
Surprise %-63.97%-86.82%-86.42%-----

DBVT Forecast FAQ

Is DBV stock a buy?

DBV stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that DBV is a favorable investment for most analysts.

What is DBV's price target?

DBV's price target, set by 15 Wall Street analysts, averages $46.33 over the next 12 months. The price target range spans from $40 at the low end to $51 at the high end, suggesting a potential 102.58% change from the previous closing price of $22.87.

How does DBV stock forecast compare to its benchmarks?

DBV's stock forecast shows a 102.58% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for DBV over the past three months?

  • January 2026: 16.67% Strong Buy, 66.67% Buy, 0% Hold, 16.67% Sell, 0% Strong Sell.
  • December 2025: 25.00% Strong Buy, 50.00% Buy, 0% Hold, 25.00% Sell, 0% Strong Sell.
  • November 2025: 50.00% Strong Buy, 25.00% Buy, 0% Hold, 25.00% Sell, 0% Strong Sell.

What is DBV’s EPS forecast?

DBV's average annual EPS forecast for its fiscal year ending in December 2024 is $-4.88, marking a 542.11% increase from the reported $-0.76 in 2023. Estimates for the following years are $-4.42 in 2025, $-6.35 in 2026, $-5.14 in 2027, and $-2.43 in 2028.

What is DBV’s revenue forecast?

DBV's average annual revenue forecast for its fiscal year ending in December 2024 is $3.1M, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $3.17M, followed by $37.55M for 2026, $143.32M for 2027, and $317.48M for 2028.

What is DBV’s net income forecast?

DBV's net income forecast for the fiscal year ending in December 2024 stands at $-465M, representing an 538.90% increase from the reported $-72.726M in 2023. Projections indicate $-421M in 2025, $-604M in 2026, $-489M in 2027, and $-231M in 2028.